Related Experiment Video
Updated: Jun 7, 2026
Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
Role of matrix metalloproteinase-3 in neurodegeneration
1Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul, Korea.
Abstract:
Matrix metalloproteinase-3 (MMP-3) is a member of the class of zinc-dependent proteases known to degrade the extracellular matrix. MMP-3 activity is regulated at three different levels: gene expression, proteolytic activation of the zymogen, and inhibition by the endogenous tissue inhibitors of metalloproteinase. A line of evidence indicates a role of MMP-3 in neurodegeneration. In neuronal cells, MMP-3 expression is increased in response to cell stress, and the cleaved, active MMP-3 participates in apoptotic signaling. In the extracellular space, MMP-3 triggers microglia to produce proinflammatory and cytotoxic molecules as well as MMP-3, which in turn contribute to neuronal damage. MMP-3 is increased in various experimental models of Parkinson's disease that are produced by selective toxins and by inflammagen, and the neuronal death is attenuated by various ways that inhibit MMP-3. α-Synuclein, whose gene mutations are associated with familial forms of Parkinson's disease, is proteolyzed by MMP-3. Contribution of MMP-3 toward the pathogenesis of Alzheimer's disease and other neurodegenerative diseases has also been suggested. Thus, modulation of MMP-3 expression and/or activity could be of therapeutic value for neurodegenerative diseases.
Insights
Matrix metalloproteinase-3 (MMP-3) plays a key role in neurodegeneration by damaging neurons and triggering inflammatory responses. Inhibiting MMP-3 activity shows therapeutic potential for treating neurodegenerative diseases like Parkinson's and Alzheimer's.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Matrix metalloproteinase-3 (MMP-3) is a protease involved in extracellular matrix degradation.
- MMP-3 activity is tightly regulated at multiple levels.
- Evidence suggests MMP-3 contributes to neurodegenerative processes.
Purpose of the Study:
- To explore the role of MMP-3 in neurodegeneration.
- To investigate MMP-3's involvement in Parkinson's disease pathogenesis.
- To assess the therapeutic potential of modulating MMP-3 in neurodegenerative diseases.
Main Methods:
- Examining MMP-3 expression in neuronal cells under stress.
- Investigating MMP-3's effect on microglial activation and cytokine production.
- Analyzing MMP-3 levels in experimental models of Parkinson's disease.
- Assessing the impact of MMP-3 inhibition on neuronal death.
- Studying the proteolysis of alpha-synuclein by MMP-3.
Main Results:
- MMP-3 expression increases in neurons during stress, promoting apoptosis.
- Extracellular MMP-3 activates microglia, leading to neuroinflammation and damage.
- Elevated MMP-3 levels are observed in Parkinson's disease models.
- Inhibition of MMP-3 attenuates neuronal death in these models.
- MMP-3 proteolyzes alpha-synuclein, a protein linked to familial Parkinson's disease.
Conclusions:
- MMP-3 is implicated in the pathogenesis of Parkinson's disease and potentially other neurodegenerative conditions.
- Targeting MMP-3 offers a promising therapeutic strategy for neurodegenerative diseases.
- Further research into MMP-3 modulation could yield novel treatments.
